HB2246Enacted

Amends TCA Title 63 and Title 68.

Tennessee HB2246 establishes regulations regarding the retrieval, manufacture, storage, and use of stem cells for stem cell therapy. The bill affects healthcare providers and facilities involved in stem cell therapy, as well as patients receiving such treatments. Key provisions include specific requirements for the handling and application of stem cells to ensure safety and compliance with state standards.

What moved, what's on next week's agenda, new filings — every Monday, from the public record, free.

No account. Unsubscribe in one click.

Overview

Tennessee HB2246 establishes regulations regarding the retrieval, manufacture, storage, and use of stem cells for stem cell therapy. The bill affects healthcare providers and facilities involved in stem cell therapy, as well as patients receiving such treatments. Key provisions include specific requirements for the handling and application of stem cells to ensure safety and compliance with state standards.

Track Tennessee Legislation Like a Pro

Join hundreds of professionals using LegisGo to stay ahead of legislative changes.

Instant Alerts

Get notified when bills you track move through the legislature

AI Summaries

Understand complex legislation in seconds with AI-powered analysis

Full Access

All 132 legislators, committee schedules, and voting records

Sponsor

Hurt, Chris

Details
Session

114th General Assembly

Introduced

February 2, 2026

Last Action

May 26, 2026

Pub. Ch. 1016

Subjects
Health CarePhysicians and Surgeons

Want to track this bill? Get instant alerts and AI-powered insights.

HB2246: Amends TCA Title 63 and Title 68. | LegisGo